Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT

4Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Aims: To determine the frequency of ketonaemia in pregnant women with type 1 diabetes treated with a sensor-augmented pump (SAP) in predictive low glucose suspend (PLGS) mode compared with low glucose suspend (LGS) mode. Methods: An open-label crossover pilot RCT in ten women with type 1 diabetes treated with a 640 Medtronic insulin pump, with inclusion between 12–30 weeks of pregnancy. Participants were 1/1 randomly assigned (allocation by statistician using a permuted block size of 2) to either 2 weeks with an SAP in PLGS mode or 2 weeks in LGS mode. After the first 2 weeks, participants were switched to the other mode. Ketones in the participants’ serum were measured three times daily (fasting, midday and evening) during the 4 weeks. The primary endpoint was the frequency of blood ketones > 0.6 mmol/l. Participants and healthcare providers were not blinded to group assignment for assessment of outcomes. Results: The median gestational week at inclusion was 12.5 weeks (12.0–15.0), participants had a median age of 31.5 years (24.0–33.0), BMI of 26.6 kg/m2 (24.5–31.8), baseline HbA1c of 41 mmol/mol (40–43; 5.9% [5.8–6.1]) and baseline time in range (TIR, 3.5–7.8 mmol/l) of 64.6% (55.6–68.7). Comparing the LGS mode with the PLGS mode, insulin suspension time per day was 2.0 h (1.3–2.3) vs 3.5 h (3.3–5.0; p = 0.002), ketonaemia > 0.6 mmol/l was 0% vs 0.5% (p = 1.000) and no participants had ketonaemia > 1 mmol/l. TIR on LGS was 64.7% (58.0–68.7) vs 61.1% (56.5–67.5) on PLGS (p = 0.492), time < 3.5 mmol/l was higher on LGS at 7.5% (4.6–8.3) vs 4.2% (2.4–6.9) on PLGS (p = 0.014). Treatment satisfaction and fear for hypoglycaemia were similar whether using LGS or PLGS mode. Conclusions/interpretation: Despite longer time periods with suspended insulin delivery, pregnant women using an SAP in PLGS mode were not at higher risk of developing ketonaemia compared with those in LGS mode. Women with an SAP in PLGS mode had similar TIR with less time in hypoglycaemia. Trial registration: Clinical Trials NCT04292509 Funding: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. Graphical abstract: [Figure not available: see fulltext.]

Cite

CITATION STYLE

APA

Benhalima, K., van Nes, F., Laenen, A., Gillard, P., & Mathieu, C. (2021). Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT. Diabetologia, 64(12), 2725–2730. https://doi.org/10.1007/s00125-021-05589-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free